Target Healthcare REIT (THRL) Share Price, News & Analysis

Company Overview

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.

Key Stats

• Today's Range: 106.79 to 108.20
• 50-Day Range: 98.50 to 108.80
• 52-Week Range: 92 to 109.20
• Volume: 204,362 shs
• Average Volume: 5.28 million shs
• Market Capitalization: £669.86 million
• P/E Ratio: 8.59
• Dividend Yield: 5.77%
• Price Target: GBX 101
• Consensus Rating: Hold

Target Healthcare REIT Stock Analysis - MarketRank™

Target Healthcare REIT scored higher than 33% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

Target Healthcare REIT has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Downside Risk

Target Healthcare REIT has a consensus price target of GBX 101, representing about 5.4% downside from its current price of GBX 106.79.

Amount of Analyst Coverage

Target Healthcare REIT has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Target Healthcare REIT is 8.50, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.15.

Price to Earnings Ratio vs. Sector

The P/E ratio of Target Healthcare REIT is 8.50, which means that it is trading at a less expensive P/E ratio than the Real Estate sector average P/E ratio of about 15.81.

Price to Earnings Growth Ratio

Target Healthcare REIT has a PEG Ratio of 1.48. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Target Healthcare REIT has a P/B Ratio of 0.96. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for THRL.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

Target Healthcare REIT is a leading dividend payer. It pays a dividend yield of 5.77%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Target Healthcare REIT does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Target Healthcare REIT is 47.10%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.67

News Sentiment

Target Healthcare REIT has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.83 average news sentiment score of Real Estate companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Target Healthcare REIT this week, compared to 0 articles on an average week.

Search Interest

1 people have searched for THRL on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Target Healthcare REIT insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.03% of the stock of Target Healthcare REIT is held by insiders.

Percentage Held by Institutions

48.84% of the stock of Target Healthcare REIT is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

THRL Stock Analysis - Frequently Asked Questions

How have THRL shares performed this year?

Target Healthcare REIT's stock was trading at GBX 97.60 on January 1st, 2026. Since then, THRL shares have increased by 9.4% and is now trading at GBX 106.79.

How were Target Healthcare REIT's earnings last quarter?

Target Healthcare REIT (LON:THRL) announced its quarterly earnings data on Wednesday, March, 18th. The company reported $3.38 earnings per share for the quarter. Target Healthcare REIT had a trailing twelve-month return on equity of 10.73% and a net margin of 104.45%.
Read the conference call transcript.

How do I buy shares of Target Healthcare REIT?

Shares of THRL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Target Healthcare REIT own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Target Healthcare REIT investors own include Realty Income (O), AT&T (T), Cambian Group (CMBN), Meta Platforms (META), Pfizer (PFE), Primary Health Properties (PHP) and Aviva (AV).

Company Calendar

• Last Earnings: 3/18/2026
• Today: 5/07/2026

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Real Estate
• Industry: REIT - Healthcare Facilities
• Sub-Industry: N/A
• Current Symbol: LON:THRL
• CIK: N/A
• Web: www.targethealthcarereit.co.uk
• Phone: +44-131-6252951
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Target Healthcare REIT: GBX 101
• High Price Target: GBX 101
• Low Price Target: GBX 101
• Potential Upside/Downside: -6.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 12.57
• Trailing P/E Ratio: 8.58
• Forward P/E Ratio: 17.33
• P/E Growth: 1.48
• Net Income: £72.07 million
• Net Margins: 104.45%
• Pretax Margin: N/A
• Return on Equity: 10.73%
• Return on Assets: 3.86%

Debt

• Debt-to-Equity Ratio: 27.14
• Current Ratio: N/A
• Quick Ratio: 1.52

Sales & Book Value

• Annual Sales: £83.69 million
• Price / Sales: 7.99
• Cash Flow: GBX 7.50 per share
• Price / Cash Flow: 14.37
• Book Value: GBX 111.13 per share
• Price / Book: 0.97

Miscellaneous

• Outstanding Shares: 620,237,000
• Free Float: N/A
• Market Cap: £668.62 million
• Optionable: Not Optionable
• Beta: 0.69